Ipilimumab vs Trazodone
Ipilimumab vs Trazodone: Overview
This comparison examines the pharmacological differences between Ipilimumab and Trazodone.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Trazodone — 5-9 hours.
Chemical Properties
Molecular Formula: Trazodone — C19H22ClN5O.
Molecular Weight: Trazodone — 371.8640 g/mol.
Type: Ipilimumab — Antibody; Trazodone — Small molecule.